γδ T cell-based adoptive cell therapyVγ9Vδ2 T cell-based adoptive cell therapyBiliary tract cancerBTCGEO
…herapies achieving complete responses in only 2–5% of patients. γδ T cell-based adoptive cell therapy represents a promising strategy due to MHC-independent activati…